Overview

Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)

Status:
RECRUITING
Trial end date:
2026-01-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the preliminary efficacy of single SC administration of MBX 1416 at 2 dose levels in patients with PBH
Phase:
PHASE2
Details
Lead Sponsor:
MBX Biosciences